Global 3D Bioprinting Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028: Increasing demand for 3D bioprinting in pharmaceuticals industry and growing prevalence of cardiovascular diseases are some of the major factors driving the growth of the Global 3D Bioprinting Market.
The 3D Bioprinting Market is valued at USD 1.84 Billion in 2021 and is expected to reach USD 6.21 Billion by 2028 with a CAGR of 18.96% over the forecast period.
Scope-
Three-dimensional (3D) bioprinting refers to the use of 3D printing-like techniques to assemble biomaterials to produce cells, growth factors, and/or biomedical parts, often with the intent of mimicking natural tissue characteristics. Typically, 3D bioprinting uses a layer-by-layer method to deposit materials known as bio-inks to create tissue-like structures that are used in various medical and tissue engineering fields. 3D bioprinting encompasses a wide range of bioprinting techniques and biomaterials. Bioprinting can be used to print models of tissues and organs to help research drugs and potential treatments. However, translating printed living cellular constructs into clinical applications faces many challenges due to the complexity and cell numbers required to create functional organs.
The outbreak of COVID-19 has positively impacted the 3D bioprinting industry. The pandemic has changed the lives of people around the world, with the number of cases increasing rapidly. The pandemic has resulted in an increase in the number of coronavirus patients worldwide and strained the health care sector with limited hospital staff. Therefore, in response to the increasing cases of coronavirus, many 3D bioprinting companies are responding to the crisis by offering their expertise to reduce the burden on supply chains and governments. Due to the everincreasing cases of COVID-19, the demand for 3D bioprinters is increasing in the market.
Key PlayersSome major key players for the global 3D bioprinting market report cover prominent players like -
• 3D Bioprinting Solutions
• Electro Optical Systems
• Foldink Life Science Technologies
• Advanced Solutions Life Sciences LLC
• Aspect Biosystems Ltd.
• Allevi Inc.
• Bico group ab
• Bio3D Technologies Pte. Ltd.
• Collplant Biotechnologies Ltd.
• Cellink Global
• Cyfuse Biomedical K.K.
• EnvisionTEC Inc.
• Formlabs Inc.
• GE Healthcare
• others
Market Segmentation-
By Technology:
• Multi-phase Jet Solidification
• Stereolithography (SLA)
• Selective Laser Sintering
• Laminated Object Manufacturing (LOM)
• Electron Beam Melting
• Fused Deposition Modeling (FDM)
• Inkjet Printing
By Application:
• Medical Sensors
• Surgical Simulation & Training Models
• Prosthetic Devices
• Orthopedic Implants
• Tissue Engineering & Regenerative Medicine
• Dental Implants
• Others
By End-User:
• Contract Research Organizations
• Medical Device Manufacturers
•
•
pharmaceutical Companies
By Regional & Country Level:
• NorthAmerica
o U.S. o Canada
• Europe o U.K. o France o Germany o Italy
• AsiaPacific o China o Japan o India o Southeast Asia
• LatinAmerica o Brazil o Mexico
• MiddleEastandAfrica o GCC o Africa o Rest of Middle East and Africa
Asia Pacific Holds a Major Share in the Global 3D Bioprinting Market:
Geographically, Asia Pacific is holding a major share in the global 3D bioprinting market due to the increasing geriatric population, and other growing investment of government in research & development these factors boost the market
Recent Developments-
CELLINK Established the Centre of Excellence in India with a Focus on 3D Bioprinting
On August 19th, 2022; CELLINK, a global leader in developing 3D bioprinters, and the Indian Institute of Science (IISc) have announced a partnership to establish a Center of Excellence (CoE) for 3D bioprinting in Bangalore, India. The CoE, the first of its kind in the field, is housed at
the Center for Biosystems Science and Engineering (BSSE) at IISc. The Center of Excellence will provide access to 3D bioprinting systems, allowing researchers to accelerate their work in critical applications with the goal of improving health outcomes.
Brinter Launched World's First Multi-Material, Multi-Fluidic 3D Bioprinting Tool
On June 22nd, 2022; A Finland-based bioprinting firm, Brinter, launched what it claims is the world's first multi-material, multi-fluidic bioprinting printhead. Designed for use with the firm's own 3D bioprinters, the digital multifluidic printing tool head is currently in pilot testing with limited customers. Aimed at research institutions and pharmaceutical companies, the device is defined by its broad material capabilities and hopes to enable high-precision tissue engineering and regenerative medicine applications, including tissue damage repair, biological function modification, and local disease treatment.
CELLINK Launched the BIO MDX Series Designed for high-throughput Biofabrication and Precise 3D Bioprinting
On March 22nd, 2021; CELLINK, the world's leading bioconversion company, launched the BIO MDX™ series, the next generation of bioprinters designed for high-throughput bio-fabrication and precision 3D bioprinting for biomedical manufacturing, including biocompatible medical devices. Over the past 5 years, 3D bioprinting has become the method of choice for researchers in tissue engineering, cell culturing, and regenerative medicine, creating a greater need for improved automation, precision, and reproducibility in bio-fabrication methods.
Key Benefits-
• Global 3D Bioprinting Market report covers in-depth historical and forecast analysis
• Global 3D Bioprinting Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global 3D Bioprinting Market report helps to identify opportunities in marketplace.
• Global 3D Bioprinting Market report covers extensive analysis of emerging trends and competitive landscape.
